Genome-wide association studies have revealed that single-nucleotide polymorphisms residing in the intergenic region between estrogen receptor 1 (ESR1) and coiled-coil domain containing 170 (CCDC170) at 6q25.1 are associated with breast cancer risk. This evidence concerns the gene ESR1 and breast cancer.